Groton, MA, United States of America

Neil Westlund


 

 

Average Co-Inventor Count = 4.6

ph-index = 2

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2011-2015

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):

Title: The Innovative Contributions of Neil Westlund in the Field of Pharmaceuticals

Introduction

Neil Westlund, an accomplished inventor based in Groton, MA, has made significant strides in the pharmaceutical industry, demonstrating a strong commitment to innovation through his nine patents. His inventive work primarily focuses on the development of novel compounds aimed at treating cell proliferative disorders such as cancer.

Latest Patents

Westlund's most recent patents include groundbreaking work on substituted tricyclic pyrazolo-pyrimidine compounds and substituted pyrazolo-pyrrolo-pyridine-dione compounds. The former patent details methods of synthesizing these compounds, alongside pharmaceutical compositions that utilize them for treating various cell proliferative disorders, including cancer. Similarly, his patent related to substituted pyrazolo-pyrrolo-pyridine-dione compounds outlines the synthesis processes and therapeutic applications that can be utilized to benefit patients suffering from cancer.

Career Highlights

Neil Westlund has dedicated his efforts to Arqule, Inc., where he has played an essential role in advancing the research and development of innovative pharmaceutical solutions. His contribution to the company has been fundamental in providing new therapeutic options for critical health issues, particularly in oncology.

Collaborations

Throughout his career, Westlund has collaborated with notable colleagues, including Mark Anthony Ashwell and Rocio Palma. These partnerships have fostered a collaborative environment where innovative ideas can thrive, further enhancing the development of impactful pharmaceutical treatments.

Conclusion

Neil Westlund continues to be a pivotal figure in the realm of pharmaceutical innovations. His dedication to researching and developing novel compounds not only embodies the spirit of invention but also holds the potential for significant advancements in the treatment of cancer and other cell proliferative disorders. His work at Arqule, Inc. reflects a commitment to improving patient outcomes through innovative pharmaceutical solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…